TFFP
Tff Pharmaceuticals, Inc.
No insider bought or sold Tff Pharmaceuticals, Inc. in the last 12 months
TFFP over the last year
Prices for TFFP aren't in yet.
TFFP after insider buys
3 months after each buy, from the first price a copier could get.
3 buys since 2019 with 3 months of prices.
Every filing
36 insider filings since 2019, newest first
Carlson Capital L P · 10% owner
Harlan F Weisman · President and CEO
Zamaneh Mikhak · Chief Medical Officer
Harlan F Weisman · President and CEO
Harlan F Weisman · President and CEO
Randy H Thurman · Director
Aaron G.l. Fletcher · Director
Glenn R. Mattes · President and CEO
Aaron G.l. Fletcher · Director
Glenn R. Mattes · President and CEO
Lung Therapeutics, Inc. · 10% owner
Stephen Rocamboli · Director
Glenn R. Mattes · President and CEO
Kirk Allen Coleman · CFO, Secretary and Treasurer
Glenn R. Mattes · President and CEO
Kirk Allen Coleman · CFO, Secretary and Treasurer
Robert S Mills · Director
Glenn R. Mattes · President and CEO
Kirk Allen Coleman · CFO, Secretary and Treasurer
Glenn R. Mattes · President and CEO
Kirk Allen Coleman · CFO, Secretary and Treasurer
Robert S Mills · Director
James Brian Windsor · Chief Science Officer
Lung Therapeutics, Inc. · 10% owner
Aaron G.l. Fletcher · Director
Malcolm Fairbairn · Director
Randy H Thurman · Director
Stephen Rocamboli · Director
Kirk Allen Coleman · CFO, Secretary and Treasurer
Glenn R. Mattes · President and CEO
Aaron G.l. Fletcher · Director
Glenn R. Mattes · President and CEO
James Brian Windsor · Chief Science Officer
Harlan F Weisman · Director
Randy H Thurman · Director
Robert S Mills · Director
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.